Sleeping With The Enemy? Open Mind Needed For Tech Giant Partnerships

Data Is An Enabler But Customization Is Key

The entry of tech giants Amazon and Alphabet into healthcare has the potential to disrupt the industry, but can established pharma players partner with them in the move towards a customer and data-oriented future? Panelists from Gilead, Merck KGaA, Bristol-Myers Squibb and others deliberated the question at a recent summit.

AI
Healthcare Is Increasingly Intersecting With Technology • Source: Shutterstock

If there’s one thing the C-suite at pharma companies is keeping a watch on these days, apart from COVID-19-related developments, it is the moves of technology giants in healthcare.

Though Amazon has entered the pharmacy business and Alphabet’s Verily Life Sciences LLC has a stated mission to make the world’s health data useful, industry is acutely aware of the customer savvy and big data capabilities the two bring to the table and their potential to disrupt the status quo

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

More from Scrip